Enzychem Lifesciences Corporation (KOSDAQ:183490)
1,135.00
-23.00 (-1.99%)
Sep 19, 2025, 2:35 PM KST
Enzychem Lifesciences Revenue
Enzychem Lifesciences had revenue of 16.40B KRW in the quarter ending June 30, 2025, a decrease of -16.34%. This brings the company's revenue in the last twelve months to 72.71B, down -14.28% year-over-year. In the year 2024, Enzychem Lifesciences had annual revenue of 77.38B with 1.76% growth.
Revenue (ttm)
72.71B
Revenue Growth
-14.28%
P/S Ratio
1.24
Revenue / Employee
559.33M
Employees
130
Market Cap
89.90B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 77.38B | 1.34B | 1.76% |
Dec 31, 2023 | 76.04B | 49.40B | 185.46% |
Dec 31, 2022 | 26.64B | 3.66B | 15.94% |
Dec 31, 2021 | 22.98B | -2.84B | -11.01% |
Dec 31, 2020 | 25.82B | -5.65B | -17.96% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
LigaChem Biosciences | 148.28B |